The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg.
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...
Hosted on MSN
The breakthrough drug transforming HIV prevention: FDA-approved lenacapavir protects with twice-yearly injections
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
Icatibant is a generic drug that is given as an injection under the skin to treat sudden attacks of hereditary angioedema (HAE) in adults. It starts working to improve your symptoms soon after you ...
The following article was originally published in Preventing Infection in Ambulatory Care, the quarterly e-publication from the Association for Professionals in Infection Control and Epidemiology ...
The Food and Drug Administration has given Viatris permission for iron sucrose injection, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results